Coronary revascularization in patients with coronary artery disease and chronic kidney disease.
There is a remarkable lack of randomized trial data on optimal management of coronary artery disease (CAD) in patients with chronic kidney disease (CKD). In fact, patients with CKD are often excluded from randomized trials that compare different treatment strategies for CAD. Because the most common cause of death in CKD patients is cardiovascular disease, it is crucial that studies are designed to determine the best therapy for CAD in this high-risk group. This article discusses the available data on coronary revascularization outcomes in CKD patients.
Keeley
Ellen C
EC
Department of Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas 75390-8837, USA. Ellen.Keeley@UTSouthwestern.edu
McCullough
Peter A
PA
D002908:Chronic Disease; D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000209:etiology / Q000601:surgery*; D006801:Humans; D007674:Kidney Diseases / Q000150:complications*; D016896:Treatment Outcome